Literature DB >> 17889516

Acute lung injury associated with docetaxel and bevacizumab.

A Prat, P Martínez, C Serrano, M A Montero, J Andreu, J Cortés.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17889516     DOI： 10.1016/j.clon.2007.08.010

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  5 in total

1.  Diffuse alveolar haemorrhage may be associated with intravitreal injection of bevacizumab in a patient with systemic risk factors.

Authors:  Ruriko Seto; Hideto Yamada; Hiroshi Wada; Makoto Osawa; Taishi Nagao; Yasutaka Nakano
Journal:  BMJ Case Rep       Date:  2011-02-02

2.  Interstitial pneumonia during bevacizumab-based chemotherapy for colorectal cancer.

Authors:  Shingo Tamura; Hitoshi Kusaba; Naoki Kubo; Kayo Ijichi; Kenji Tsuchihashi; Masato Komoda; Keita Uchino; Hiroshi Ariyama; Koichi Akashi; Eishi Baba
Journal:  Med Oncol       Date:  2014-01-30       Impact factor: 3.064

3.  Bevacizumab-Induced Pneumonitis in a Patient With Metastatic Colon Cancer: A Case Report.

Authors:  Sami Pervaiz; Sylvester Homsy; Naureen Narula; Sam Ngu; Dany Elsayegh
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2020-06-15

4.  Clinical Characteristics and Risk Factors of Lung Injury Induced by Nab-Paclitaxel.

Authors:  Keiichiro Yoshioka; Mitsuhiro Abe; Yuki Shiko; Ken Koshikawa; Yohei Kawasaki; Shunichiro Iwasawa; Jiro Terada; Kenji Tsushima; Koichiro Tatsumi; Takuji Suzuki
Journal:  Drug Des Devel Ther       Date:  2022-03-22       Impact factor: 4.162

5.  Pneumonitis and pulmonary fibrosis in a patient receiving adjuvant docetaxel and cyclophosphamide for stage 3 breast cancer: a case report and literature review.

Authors:  Roberto Ochoa; Pablo A Bejarano; Stefan Glück; Alberto J Montero
Journal:  J Med Case Rep       Date:  2012-11-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.